Happy Sunday investors and traders ! We wanted to

New Post Public Reply Private Reply Replies (0) Message Board

MicroCapStocksRock StockMasterTalk #36879

Mar 16, 2014 at 12:35 PM

Happy Sunday investors and traders ! We wanted to take the time when the market was closed to discuss the following three stocks, HHSE NTEK and MFST. Our due diligence has uncovered some pretty amazing things going on between NTEK and HHSE and between NTEK and MFST. We have alerted all three companies here on FISP and we own these three and continue adding more shares on all three. The reason why is simple, they all make $$$ and all are increasing their revenues by coming together and doing joint ventures with each other which then adds to their bottom lines. We love the CEOs at each company too. All very savvy men with solid business skills that have led their companies to profitability and increased cash flows. Let us take some time below to discuss each company and the due diligence we have compiled on each hot company to own. We also believe that each stock is VERY undervalued at their current PPS and that will soon change as more and more folks find out about each company. The supply of shares in the market will dwindle while demand for the shares in these companies soars with their increasing revenues, profits and business developments. We are buyers of all three of these stocks based on our due diligence of these companies. We are not financial advisors so be sure to do your own due diligence of the companies and do not buy these companies based on our due diligence alone. Do your homework and you will see why we are buying these three stocks.

HHSE

Hannover House became a publicly traded company in late 2009 when it reverse merged into the TDGI shell and subsequently went through a name and symbol change to HHSE. The stock went from 0.0015 to as high as 6.6 cents and was in a blue sky breakout but unfortunately the previous shell owner sold into that run with shares he should never have had. That unfortunate event is the only reason the stock is not well above 15-25 cents. The company in the meantime went through some growing pains and learned from a few business mistakes and has now become a very smart and savvy company with stronger margins and a business plan that is developing into one that will see the company at much much higher PPS prices. The company management gets it. They have an investors blog they use regularly to communicate with the investment community. They are very protective of their share structure. They reduce the share structure over time as they can with share retirements and the management conducts their business and investor relations as if it were a fully transparent Nadsaq company with annual shareholder meetings in person with management, the investor blog, disclosure statements and now 8K filings. The company is voluntarily submitting 8Ks, 10Qs to SEC Edgar system and will soon have their Form 10 and 2 years of audited financials approved for the move to OTCQB, expected any time now. Eric Parkinson who was the CEO of Hemdale (a Nasdaq Company) knows the entertainment business better than most. He is very connected to Hollywood and all the major motion picture companies and has strong business relationships with all major retailers including Walmart, Bet Buy, Amazon, etc. The company jointly announced that they will be launching VODwiz which is a joint venture between HHSE and NTEK to provide the general public video on demand service for thousands of independent titles. This internet streaming service is another choice like Netflix or Hulu but brings thousands of titles not available through these other content providers. We love the HHSE potential as both a company and a VERY undervalued stock. We are buyers of the stock indefinitely. From a charting perspective, the stock has a golden cross forming on the daily chart and it looks as though that powerful technical event will take place in the very near future. See Daily chart below.

NTEK

Nanotech Entertainment (OTC: NTEK) is the HOTTEST Tech stock on the OTC by far. The company is making money hand over fist. They are projected to do $33M in revenues for 2014. They have announced quarterly dividends that will increase to shareholders as profits continue to grow. The company has developed the Nuvola NP-1. This product is the world's first streaming media player that supports 4K Ultra HD Movies. It has the fastest mobile processor on the market today and is set up with major wholesale distributors and major retailers to be announced in the near future. The company through its JV with HHSE is also partners in their own video on demand service for thousands of independent titles leveraging Hannover House's expertise in the movie industry which will mean increased profits for the company. The company has joint ventures and businss with partners such as MFST who is going to have its own ROKU channel under the NTEK umbrells for a health channel again adding revenue and profit to NTEK. NTEK is a monster high tech company that is definitely NASDAQ BX bound once it stays on the OTCQB for a specified time frame starting this summer when its audited financials and Form 10 are approved by the SEC. We love the stock and we have been using the recent pullback to buy up a ton of shares and continue to add to this winner. Dividends start paying in April. CEO is top notch. No brainer investment for one's portfolio as a tech stock. From the look of the daily chart below, we have nice bounce in procees with money flowing in, accumulation going up, MACD crosses and TRIX about to cross up. RSI has plenty of room to run too. We love the technicals on the daily NTEK chart!

MFST

Medifirst Solutions (OTCQB: MFST) is an SEC reporting medical company that is currently doing busness in New Jersey/New York area and in their new medical center in Boca Raton, Florida. Medifirst Solutions has established practice services and protocols to generate new revenues by establishing a specialized "medical services" within the practice. Medical, healthcare and wellness services and products are designed to help patients achieve better outcomes in their overall health and well-being. Using cutting-edge and innovative technology, we have created exciting new healthcare and medical services and products for the healthcare and mental health industry. They are dedicated to provide innovative drug free and pain free treatments, services and products for people to make better and healthier choices and improve their quality of life. Additionally, MFST management has decided to enter the Medical Marijuana industry with the State of Florida approving MJ as a medical treatment and several other states where Medifirst Solutions will leverage their medical expertise. They have a medical doctor on staff, Dr. Rubin is a licensed medical doctor in several states. MFST has a very solid joint venture with NTEK for a roku channel that will be used for their products and shows designed by Medifirst staff to introduce these cutting edge technologies and will publish many Medical MJ shows nationally as well. We are buyers of this stock. We love the share stucture which is only 10.2M shares in its float and 15M shares in its OS. The CEO is very respected in the industry and is very protective of its share structure and his shareholders. The sky is the limit for this company and we expect a strong move up in share price as the company gets discovered by the investment community. At this point the stock is still very much a hidden gem but that will not last much longer as marketing kicks in nationally though trade shows, TV, radio, magazines, social media and PR/IR campaigns continue positively.

My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...